Translational Surgery Graduate Program, Universidade Federal de Sao Paulo, Rua Botucatu, 740, 2º andar. Vila Clementino, São Paulo, SP, Brazil.
School of Medicine, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil.
Aesthetic Plast Surg. 2022 Oct;46(5):2124-2130. doi: 10.1007/s00266-022-02903-w. Epub 2022 May 10.
Although there is limited evidence for regulating the use of prophylactic antibiotics in reduction mammaplasty, many plastic surgeons prescribe them, even in the postoperative period. This study aimed to conduct a national survey to investigate the antibiotic prophylaxis protocols followed by Brazilian plastic surgeons in reduction mammaplasty.
An anonymous survey comprising 19 questions was sent to all 4864 active members of the Brazilian Society of Plastic Surgery (SBCP). The surgeons electronically received the invitation to participate in the survey and the link to fill out the electronic form.
In total, 859 surgeons (17.7%) responded. Most respondents (77.8%) were men and aged 35-55 years (61.5%); 58.6% of them had 10-29 years of specialty training. Only a minor proportion of the respondents (0.5%) reported not prescribing antibiotics at any time (95% confidence interval [CI]: 0.0-0.9), 9.9% (95% CI: 7.9-11.9) prescribed them only preoperatively, and 14.6% (95% CI: 12.2-16.9) prescribed continued antibiotic use for 24 h. The majority of the respondents (75.1%; 95% CI: 72.1-77.9) prescribed antibiotics for additional days after discharge. There were significant associations between antibiotic prescription and the surgeons' age group (p = 0.015), time since graduation (p < 0.001), experience in the specialty practice (p = 0.003), SBCP membership (p < 0.001), and surgical site infection rates (p = 0.011).
Most responding plastic surgeons affirmed that they prescribed prophylactic antibiotics for more than 24 h in reduction mammaplasty cases.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
尽管预防性抗生素在缩乳术的应用方面证据有限，但许多整形外科医生仍开具此类药物，甚至在术后也如此。本研究旨在进行一项全国性调查，以了解巴西整形外科医生在缩乳术中遵循的抗生素预防方案。
向巴西整形外科学会（SBCP）的所有 4864 名活跃成员发送了一份包含 19 个问题的匿名调查问卷。外科医生通过电子方式收到参与调查和填写电子表格的邀请。
共有 859 名外科医生（17.7%）做出回应。大多数受访者（77.8%）为男性，年龄在 35-55 岁（61.5%）；其中 58.6%的人接受过 10-29 年的专业培训。只有少数受访者（0.5%）表示在任何时候都不使用抗生素（95%置信区间[CI]：0.0-0.9），9.9%（95%CI：7.9-11.9）仅在术前使用抗生素，14.6%（95%CI：12.2-16.9）使用抗生素 24 小时。大多数受访者（75.1%；95%CI：72.1-77.9）在出院后会继续开其他天数的抗生素。外科医生的年龄组（p=0.015）、毕业后的时间（p<0.001）、专业实践经验（p=0.003）、SBCP 会员资格（p<0.001）和手术部位感染率（p=0.011）与抗生素处方之间存在显著关联。
大多数接受调查的整形外科医生表示，他们在缩乳术中会开具超过 24 小时的预防性抗生素。
证据等级 V：本刊要求作者为每篇文章分配一个证据等级。如需详细了解这些循证医学评级，请参考目录或网上的作者指南 www.springer.com/00266 。
